Paper Review Records
全部论文审稿周期
26 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
97
天
Pretreatment ET radiomics based on primary-tumor HR status for assessing the risk of local progression after GKRS in BCBM
作者
Sijun Diao; Tao Huang; Zhongyu Li; Shihong Zhu; Fujun Liu; Xiyue Lu; Huiyang Luo; Jing Chen展开收起
作者单位
1. Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University , Chengdu , China; 2. Department of Anesthesiology, West China Hospital, West China Medical School, Sichuan University , Chengdu , China展开收起
23
天
Endocrine resistance in HR+/HER2− breast cancer: molecular mechanisms and emerging therapeutic strategies
作者
Tong Shen; Hui Li; Xubin Zhang; Qin Zhou展开收起
作者单位
1. School of Medicine, Jiangsu University, China; 2. Department of Breast Surgery, Affiliated Kunshan Hospital of Jiangsu University, China展开收起
35
天
Stress-informed parametric shape adaptive patient-specific implant design in computer-assisted jaw reconstruction
作者
Ankit Nayak; Yu-Xiong Su; Jane Jingya Pu展开收起
作者单位
1. School of Advanced Engineering, University of Petroleum and Energy Studies (UPES), India; 2. Division of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China展开收起
64
天
Comparative efficacy of fruquintinib, regorafenib or TAS-102 in patients with KRAS-mutant metastatic colorectal cancer: a systematic review and network meta-analysis
作者
Yingyu Zhou; Shiqing Zhao; Xiaoyi Zheng; Yixuan Wang; Mingzhen Wang; Siyu Chen; Zhenan Wu; Dong Zang; Wenzhe Si展开收起
作者单位
1. Department of Laboratory Medicine, Beijing Hospital of Integrated Traditional Chinese and Western Medicine, Hospital of Integrated Traditional Chinese and Western Medicine, Beijing University of Chinese Medicine, China; 2. Department of Laboratory Medicine, National Health Commission (NHC) Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides of National Health Commission, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University Third Hospital, China; 3. Department of Biology, The College of Life Sciences and Health, Wuhan University of Science and Technology, China展开收起
126
天
A solitary brain metastasis from gastroesophageal junction adenocarcinoma 13 years after curative multimodality treatment: a case report and review of the literature
作者
Sara Di Lorenzo; Pasqualina Giordano; Giuseppe Catapano; Francesca Maria Giugliano; Piera Federico; Federico Frio; Antonio D’Antonio; Bruno Daniele; Angelica Petrillo展开收起
作者单位
1. Medical Oncology, Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Italy; 2. Medical Oncology Unit, “Cav. R. Apicella” Hospital, Italy; 3. Medical Oncology Unit, Ospedale del Mare, Italy; 4. Neurosurgery Unit, Ospedale del Mare, Italy; 5. Radiation Oncology Unit, Ospedale del Mare, Italy; 6. Pathology Unit, Ospedale del Mare, Italy展开收起
214
天
Combined analysis of preoperative circulating tumor cells status and tumor size to guide width of resection margin for solitary hepatocellular carcinoma
作者
Jiansen Xie; Qijie Luo; Dongdong Huang; Feng Xia; Zhenheng Wu; Wei Zhou; Qiao Zhang; Feng Tian; Chi-Yi Liu; Zhihui Xu; Xian-Ting Jiao; Wei-Qiao Zhang; Mo Ali; Yi Zhou; Hengyi Gao展开收起
作者单位
1. Department of Hepatobiliary Surgery, Longhua District People's Hospital, China; 2. Department of Hepatobiliary Surgery I, Zhongshan People's Hospital, China; 3. Department of Liver Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China; 4. Department of Hepatobiliary Surgery, Union Hospital, Fujian Medical University, China; 5. Department of Hepatobiliary Surgery, Xiaogan Central Hospital, China; 6. Graduate School, Guangdong Medical University, China; 7. Department of Anesthesiology I, Zhongshan People's Hospital, China; 8. Department of Anesthesiology II, Zhongshan People's Hospital, China; 9. Department of Anesthesiology, Shenzhen Longgang District People's Hospital, China; 10. Intensive Care Unit, Zhongshan People's Hospital, China; 11. Department of Hepatobiliary Surgery, The First Affiliated Hospital of Shaoyang University, China展开收起
FAQ
Frontiers in Oncology审稿要多久?
截至2026-11-19,CrushSCI 收录了 Frontiers in Oncology 的 26 篇完整审稿记录。最快一篇从收稿到录用用了 15 天(Gut microbiota-mediated chemotherapy resistance in colorectal cancer: mechanisms and precision interventions,2026-08-13 收稿,2026-08-28 录用),最慢一篇用了 280 天;平均 105.3 天,中位数 89 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
